Litcius/Paper detail

Synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual AChE and SERT ligands for Alzheimer’s disease

Julio Rodríguez-Lavado, Carlos Gallardo‐Garrido, Michael Mallea, Victor Bustos, Rodrigo Osorio, Martín Hödar-Salazar, Hery Chung, Ramiro Araya‐Maturana, Marcos Lorca, C. David Pessoa‐Mahana, Jaime Mella, Claudio Saitz, Pablo Jaque, Miguel Reyes‐Parada, Patricio Iturriaga‐Vásquez, Hernán Pessoa‐Mahana

2020European Journal of Medicinal Chemistry31 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryAcetylcholinesteraseIC50AchéDocking (animal)PharmacologyDonepezilAntidepressantContext (archaeology)In vitroSerotonin transporterBiochemistryStereochemistryEnzymeSerotoninReceptorInternal medicineNeuroscienceBiologyMedicineHippocampusPaleontologyDiseaseNursingDementiaCholinesterase and Neurodegenerative DiseasesNeuroscience and Neuropharmacology ResearchComputational Drug Discovery Methods
Synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual AChE and SERT ligands for Alzheimer’s disease | Litcius